Tags:
Permalink Reply by Blake McClellan on February 21, 2012 at 2:50pm
Permalink Reply by Robert M Teague on February 25, 2012 at 4:41am Hello Blake,
Many thanks for responding to my request. At this stage we are reaching out to identify the clinciains who are already embracing the biological approach to bone regeneration. In this we mean materials that fully resorb rather than occupy a space and positively accelerate the healing (bone regeneration) cascade and support good new bone to implant contact. Our Fortoss VITAL technology achieves this with the added feature of being totally synthetic and needing no additonal membrane. But....the protocola nd application is different to a traditional particulate so we must "prepare" the ground to motivate and support a small number of clinicians who can help influence.
At this stage we wish to identify prospects, and make an initial approach with the thought of organising a round table expert meeting to exchange dialogue and plan some initial cases.
This technology is already FDA approved and well documented but not with the US names. You can see more on our manufacturere web site www.biocomposites.com
Robert Teague (rmt@biocomposites.com)
Created by Dental Sales Rep May 14, 2008 at 7:30pm. Last updated by Dental Sales Rep Dec 9, 2010.
Josh Peterson left a comment for Stephanie Stricklin© 2012 Created by Dental Sales Rep.